patience is the name of the game
investors need to understand, TST is not a start up internet mpany that is built on some interesting ideas, ran by bunch 20 years old with the ultimate goal of nothing but financial interest ---being bought out by some venture capitals or bigger companies and striking it rich over night.
this is research oriented, very small pharm company employs what, 40ish people? this is a group of dedicated scientists and researchers that devoted almost a decade to develop a drug.
would it make more financial sense just to pass the drug to a bigger pharm and pocket all the cash and happily retire? of course it would, for shareholders. but for these type of people, to continue working to perfect the drug, to navigate their product to see the final success (commercialization) may be more an important sentiment than the financial gains.
the company took the direction it did and landed at the situation it is now, in my opinion, is not because the people leading the companies are incompetent, but simply their effort to explore the likelihood of self sufficiency, with a company this size, it does not need to take too many employees' ideology to infuence the direction it takes.
i feel bad for people who entered at 0.3 and above, but really, i believe making the SH rich overnight is nowhere near their top priority list at the moment.
that being said, the strategy it attmpted seemsfailed and you can sense the tone in the most recent NR. hopefully with the end of current strategy, the company and its employees are more motivated to take the other direction as they claimed in the previous NR.this is a solid drug, some sort of partnership to continue working from current stage is not that far fetched.
just gotta be patient, and shut up with all your cynical, smart mouth comments.